Welcome to our dedicated page for ACUITY INC, SEC filings (Ticker: AYI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Acuity Inc. (NYSE: AYI) SEC filings page brings together the company’s official regulatory disclosures, which provide detailed insight into its role as an industrial technology company focused on lighting, controls, building management, and intelligent spaces. As a U.S. public company, Acuity submits filings to the Securities and Exchange Commission that cover financial results, governance matters, and other material information.
Key documents for AYI include Form 10‑K annual reports, where Acuity discusses its two business segments—Acuity Brands Lighting and Acuity Intelligent Spaces—along with risk factors, management’s discussion and analysis, and audited financial statements. Form 10‑Q quarterly reports provide interim updates on net sales, operating profit, segment performance, and the use of non‑GAAP measures such as adjusted operating profit, adjusted diluted EPS, EBITDA, adjusted EBITDA, and free cash flow, which the company explains in its earnings materials.
Form 8‑K current reports for Acuity Inc. often furnish press releases announcing quarterly and full‑year results, as well as other material events. For example, recent 8‑Ks reference earnings releases for fiscal quarters and the full fiscal year, including segment details for ABL and AIS. The DEF 14A definitive proxy statement provides information on governance, executive compensation, company values, and the Board’s discussion of Acuity’s transformation from a principally luminaires business to a data and control and luminaires business and its renaming to Acuity Inc.
On Stock Titan, these filings are updated from EDGAR and can be paired with AI‑powered summaries that highlight key points, explain complex sections, and help readers quickly locate items such as segment disclosures, non‑GAAP reconciliations, and governance discussions. Users can review Acuity’s historical and current filings to understand how the company reports on its industrial technology strategy, financial performance, and capital allocation over time.
Acuity Inc. senior vice president and chief financial officer Karen J. Holcom reported an automatic stock transaction under a pre-arranged Rule 10b5-1 trading plan adopted on October 29, 2025.
On January 28, 2026, she exercised 897 non-qualified stock options at $239.76 per share into common stock, then sold 4,974 common shares at $309.23 per share. Following these transactions, she directly beneficially owned 21,523 shares of common stock and indirectly owned 302.3631 shares through a 401(k) plan.
An affiliate of Acuity Inc. filed a notice of proposed sale of 4,974 shares of common stock, with an aggregate market value of $1,538,110.02. These shares are to be sold through Merrill Lynch on the NYSE, with an approximate sale date of January 28, 2026.
The issuer had 30,662,621 shares of common stock outstanding. Recently acquired shares included 897 shares from an employee stock option exercise and 4,077 shares from vesting of restricted stock and performance share awards granted under the issuer’s equity compensation plan.
Acuity Inc. reported the results of its annual stockholder meeting held on January 21, 2026. Stockholders elected nine directors, including Neil M. Ashe, Marcia J. Avedon, W. Patrick Battle, and others, each receiving over 23.9 million votes in favor, with relatively few votes against or abstentions and 2,048,791 broker non-votes for each nominee.
Stockholders also ratified Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal 2026, with 25,406,971 votes for, 1,476,495 against, and 37,451 abstentions. In addition, they approved, on an advisory basis, the Company’s named executive officer compensation, with 24,398,615 votes for, 405,360 against, 68,151 abstentions, and 2,048,791 broker non-votes.
Acuity Inc. (AYI) director Mark Sachleben reported receiving 546 deferred restricted stock units (DSUs) as director compensation. The Form 4 shows that on January 21, 2026, he acquired 546 DSUs at a stated price of $0 per unit, held directly, bringing his beneficial ownership to 546 DSUs.
The DSUs were issued under Acuity’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan after he elected to receive a portion of his annual director fees in DSUs instead of cash. Each DSU represents a right to receive one share of common stock. The DSUs will vest in full on the first anniversary of the grant date or, if earlier, on the date of the next annual stockholder meeting, and will be paid upon retirement in either a lump sum or five annual installments. The number of DSUs granted was calculated using $320.59, the average of the high and low trading prices of Acuity common stock over the five trading days before the grant.
ACUITY INC. director Laura O'Shaughnessy reported an award of 546 Deferred Restricted Stock Units (DSUs) on common stock equivalent to 1-for-1, received as part of her annual director compensation. The DSUs were issued under the company's Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan after she elected to take a portion of her director fees in DSUs.
The DSUs will vest in full on the first anniversary of the January 21, 2026 grant date, or earlier if the next annual stockholders' meeting occurs sooner. Once vested, the DSUs will be settled upon retirement in either a lump sum or five annual installments. The number of DSUs granted was calculated using a reference price of $320.59, the average of the high and low trading prices of ACUITY INC.'s common stock over the five trading days immediately before the grant, and the transaction is reported as a direct holding.
Acuity, Inc. director Maya Leibman received an equity-based compensation award in the form of deferred restricted stock units. On 01/21/2026, she was granted 546 Deferred Restricted Stock Units (DSUs) at a price of $0 per unit under the company’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan.
The DSUs were issued because she elected to receive a portion of her annual director fees in DSUs instead of cash. The number of DSUs was based on $320.59, the average of the high and low sales prices of Acuity’s common stock over the five trading days immediately before the grant date. The DSUs vest in full on the first anniversary of the grant date, or earlier if the next annual stockholder meeting occurs sooner, and will be paid out after retirement either in a lump sum or over five annual installments.
Acuity Inc. director James H. Hance Jr. reported receiving a restricted stock award of 546 shares of common stock on January 21, 2026. The shares were valued at $320.59 per share and were taken in lieu of a portion of his annual director fees, reflecting compensation paid in stock instead of cash.
After this grant, Hance directly beneficially owns 18,618 shares of Acuity Inc. common stock. The restricted stock will vest in full on the first anniversary of the grant date, or earlier if the next annual meeting of stockholders occurs before that date.
Acuity Inc. director George Douglas Dillard Jr. received an award of 546 Deferred Restricted Stock Units (DSUs) on 01/21/2026 as reported on a Form 4. These DSUs were granted under Acuity’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan based on his election to take a portion of annual director fees in DSUs rather than cash.
The number of DSUs was calculated using a reference price of $320.59, which was the average of the high and low sales prices of Acuity common stock over the five trading days immediately before the grant date. The DSUs vest in full on the first anniversary of the grant date or, if earlier, on the date of the next annual meeting of stockholders, and will be settled after retirement in either a lump sum or five annual installments on a one-for-one basis in Acuity common shares.
Acuity Brands director Michael J. Bender received 546 Deferred Restricted Stock Units (DSUs) on January 21, 2026. These derivative awards were acquired at a stated price of $0 per unit as part of his annual director compensation.
The DSUs were issued under Acuity’s Amended and Restated 2012 Omnibus Stock Incentive Compensation Plan following Bender’s election to take a portion of his director fees in DSUs rather than cash. Each DSU is exchangeable on a 1‑for‑1 basis for a share of Acuity common stock.
The DSUs will vest in full on the first anniversary of the grant date, or earlier if the next annual stockholder meeting occurs sooner. After vesting, they will be paid out upon Bender’s retirement, either in a lump sum or in five annual installments. The number of DSUs granted was based on a reference stock price of $320.59, calculated as the average of the high and low trading prices over the five trading days before the grant.
Acuity Inc. director W. Patrick Battle reported receiving 546 Deferred Restricted Stock Units (DSUs) on January 21, 2026. These derivative securities were acquired at $0 per unit as part of his annual director compensation, reflecting his election to take a portion of fees in DSUs instead of cash.
Each DSU is exchangeable on a 1-for-1 basis for a share of Acuity common stock. The DSUs will vest in full on the first anniversary of the grant date or, if earlier, on the date of the next subsequent annual meeting of stockholders following the grant. After vesting, they become payable upon Battle’s retirement, either in a single lump sum or in five annual installments.
The number of DSUs was determined using $320.59 as the reference price, which was the average of the high and low sales prices of Acuity’s common stock over the five trading days immediately before the grant date.